Prenatal tests
Carrier screening and cell-free DNA tests: what to know
Your decision
At a glance
- Who is tested
- The parents’ genes, not the baby’s. If the first person tested has a carrier result, the partner is usually offered testing too.
- When
- Before pregnancy or at any time during pregnancy. No set week is given, so ask at your first visit.
- Routine or optional
- Optional. ACOG says it is your choice, and there is no right or wrong choice.
- The sample
- A sample of blood, saliva or tissue from inside the cheek, according to ACOG.
- Results
- Ask the office when results come back and who will call you.
What it is
Carrier screening is a genetic test that shows whether a person carries a gene for certain inherited conditions. Done before or during pregnancy, it shows the chances of having a child with one of them. It is a screening test, which shows a chance and does not say whether this baby has a condition. A diagnostic test is the kind that can show whether a baby has a specific condition.
Carrier screening is not the same test as cell-free DNA screening. Carrier screening tests the parents’ genes, not the baby, and can be done before or during pregnancy. Cell-free DNA screening, often called NIPT, is a blood test that looks at small pieces of DNA from the placenta in the pregnant person’s blood. It estimates the chance of certain chromosome conditions in the baby, and it can usually be done from about week 10 of pregnancy.
The conditions cell-free DNA screening looks at are chromosome conditions, which are caused by missing or extra chromosomes. It is a screening test, not a diagnosis, and ACOG says it does not test for many other chromosomal and genetic disorders. Only the pregnant person gives a blood sample, so no sample from the partner is needed. ACOG and the Society for Maternal-Fetal Medicine (SMFM) say it should be offered to everyone who is pregnant, whatever their age or risk, and it is optional.
A carrier has one changed copy of a gene and one that works. ACOG says carriers usually have no symptoms or only mild ones, and many carriers do not know they carry a gene change. With a recessive condition, a child has the condition only when they inherit a changed copy of the gene from each parent, so the parents each carry one changed copy.
Sometimes a carrier result says something about the carrier’s own health. ACMG says some people with two X chromosomes who carry certain X-linked conditions, which come from gene changes on the X chromosome, may have symptoms. A genetic counselor can explain whether a result matters for the carrier’s own health.
ACOG says everyone who is pregnant or planning a pregnancy is offered carrier screening for cystic fibrosis, hemoglobinopathies and spinal muscular atrophy (SMA), and can choose screening for more conditions. Cystic fibrosis is an inherited disease with thick, sticky mucus that mainly affects the lungs and digestion. SMA is a genetic disorder of the nerves of the spine that control muscles. Hemoglobinopathies, which include sickle cell disease and thalassemia, are genetic disorders that affect red blood cells. How severe each one is varies. A genetic counselor can explain your risks and options for a condition.
Screening can be done in different ways. Targeted screening picks conditions based on your ancestry or family history. Expanded screening tests many conditions on one sample, whatever the ancestry, using a list of conditions (a panel) that each company builds. Which conditions a test includes depends on the lab or practice and can change over time, so two tests can cover different conditions. ACMG says the lab report should state what the panel contains.
ACOG and ACMG disagree about how broad the panel should be. ACOG’s committee opinion (March 2017, reaffirmed 2025) says ancestry-based screening, the same screening offered to everyone, and expanded screening are all acceptable, and that each practice should set a standard approach it offers every patient. ACOG also says you can ask for a different approach after counseling. ACMG’s 2021 practice resource says everyone who is pregnant or planning a pregnancy should be offered a specific list of conditions chosen by ACMG, which it calls a Tier 3 panel. ACMG does not recommend narrower lists, and does not recommend routinely offering larger ones. These are two professional views. Ask which approach your practice uses and which conditions your test covers.
Anyone can be a carrier of a genetic condition. Some conditions are more common in some groups, but they are not limited to those groups. If a genetic condition runs in either partner’s family, tell your provider. ACOG says screening for that condition may be recommended whatever your ancestry, and CDC lists conditions that run in your family or your partner’s family among reasons for genetic counseling. ACOG also says most babies with genetic disorders are born to couples without risk factors. ACOG says couples who are second cousins or closer (related to each other by blood) should be offered genetic counseling about the higher chance of recessive conditions in their children.
When it happens
Carrier screening can be done before pregnancy or at any time during pregnancy. ACOG and ACMG say it is ideally done before pregnancy, because that leaves more choices.
If you are already pregnant, ACOG says carrier screening can be done at any time during pregnancy. ACOG also says that if carrier screening is done after pregnancy has started, your options are more limited if you and your partner turn out to be carriers. Ask your provider which options are still possible and by when.
The ACOG and ACMG sources listed below give no set week for carrier screening in pregnancy. Ask your practice at your first visit when it is usually done and when the results would arrive.
To see where this fits among your other visits, read the prenatal appointment schedule.
What happens
- Talk with your provider about which approach the practice uses and which conditions the test covers. ACOG says you and your ob-gyn can discuss the benefits and limits of each approach, and that you can also talk with a genetic counselor.
- You give a sample. ACOG says the test uses a sample of blood, saliva or tissue from inside the cheek. ACOG describes screening for hemoglobinopathies and for SMA as done on a blood sample.
- ACOG says the partner who is most likely to be a carrier is typically tested first. If that person is not a carrier, ACOG says no more testing is needed for that condition. If that person is a carrier, the other partner is tested for the same condition. ACOG’s committee opinions say that when a person is found to be a carrier, the partner should be offered screening. ACMG says a negative result lowers the chance but does not remove it (see “Risks and limits”).
- ACMG says that when screening is done during a pregnancy, it is ideal to screen both partners at the same time, so results arrive in time. It says testing one partner first and the other later is also an approach, and that a partner’s availability should not decide when or whether screening is offered, though how it affects the reading of the result should be discussed. Ask which your practice does.
- Ask the office when results come back and who will call you.
Risks and limits
- Risk to the baby
- ACOG says there are no risks to the fetus with any of the screening tests it lists for pregnancy, and carrier screening is one of them.
- Not every condition
- ACOG says carrier screening is available for a limited number of diseases, and ACMG says that of all genetic conditions only a minority are screened. It will also not find a new gene change (a “de novo” change) that arises in the baby and that neither parent carries.
- A negative result
- A negative carrier result lowers the chance of being a carrier or of having a child with a condition, but it does not remove it, because not every gene or gene change is known or tested. ACMG says the remaining chance is never zero and for most conditions cannot be given as an exact number. ACOG says a chance of being a carrier always remains, and that in a small number of cases test results can be wrong.
- How a condition shows up
- Carrier screening cannot tell how severe a condition would be in a child who inherits it. ACMG adds that how a condition shows up varies, even between people in the same family who have it.
- Finding out you are a carrier
- The more conditions a test covers, the more likely it is to find that a person is a carrier of at least one. ACOG says that with large panels many people may be found to be carriers of one or more conditions, which can lead to partner testing, genetic counseling and worry.
- Unclear results
- A lab may find a gene change whose meaning is unclear. ACMG says such a change is not reported unless one partner is found to carry a change in the same gene that causes a condition. The other partner should then be asked whether they want that information.
- Screening more than once
- Sources differ. ACOG says that once you have been screened for a condition you do not need to be screened for it again, and that screening for a condition is in general done once in a lifetime. ACMG says screening should be readdressed when a partner has changed, and that people who had narrower screening in an earlier pregnancy should be offered its Tier 3 panel. ACOG’s committee opinion adds that a decision to rescreen should only be made with the guidance of a genetics professional. If you were screened before, tell your provider and ask what, if anything, needs to be added.
- Privacy, family and the law
- A carrier result can matter to relatives, who may be carriers too. ACOG’s guidance for clinicians says a carrier should be encouraged to tell relatives about the risk and about carrier screening. ACOG’s patient pages say no law says you have to tell anyone, and that your results cannot be shared without your consent. If you choose to tell family members, they say your ob-gyn or a genetic counselor can advise you on the best way. ACOG and NHGRI also say a US law, the Genetic Information Nondiscrimination Act (GINA), makes it illegal for most health insurers to use genetic test results to decide on coverage or rates, and for most employers to use genetic information against employees or applicants. ACOG says GINA does not apply to life, long-term care or disability insurance, and NHGRI says some states add protection. This is a summary, not legal advice.
- Insurance coverage
- ACOG says insurance coverage for carrier screening may vary, and that some patients may want to confirm coverage or get preapproval before testing. ACMG names insurance coverage for patients and partners among the barriers to putting its recommended screening into practice. Ask your insurer what is covered for you and for your partner.
Your results
A carrier result (sometimes called a positive result) means the person has a changed copy of the gene that was tested. ACOG says carriers usually have no symptoms or only mild ones, and many do not know they carry a gene change.
What a carrier result means for a baby depends on the partner. A child has a recessive condition only when they inherit a changed copy of the gene from each parent. ACOG says the next step is to have the partner tested.
- A carrier result changes a chance. On its own it does not show that this baby has a condition.
- ACOG says a person who is a carrier of sickle cell disease or thalassemia (called having sickle cell trait or thalassemia trait) can have a healthy pregnancy, and that prenatal care is important. Whether the baby has the condition depends on the partner.
- A genetic counselor can go through a result with you and talk about your options.
When both parents carry a changed gene for the same recessive condition, ACOG says a child has a 1-in-4 chance of having the condition and a 1-in-2 chance of being a carrier. MedlinePlus Genetics adds a 1-in-4 chance of a child who is neither, and says these chances apply to each pregnancy. The National Society of Genetic Counselors says the same about the 1-in-4 chance.
If only one parent is a carrier, ACOG says there is a 1-in-2 chance of a child who is a carrier. For spinal muscular atrophy, and for sickle cell disease and thalassemia, ACOG says that if the partner’s test shows they are not a carrier, the chance of a child with the condition is very low. ACMG says a negative result in the partner lowers the chance but does not remove it, and that for most conditions the remaining chance cannot be given as an exact number. In short, lower, but not zero.
If both partners are carriers of the same condition, ACOG says to talk with a genetic counselor or a doctor who specializes in genetics. ACOG’s committee opinions say genetic counseling should be offered or encouraged, and ACMG says counseling by an appropriately trained professional is recommended when a couple is found to be at risk. Ask your provider or a genetic counselor to explain your result and the next steps.
If you learn before a pregnancy that you are both carriers of the same condition, ACOG says you have several options. They include getting pregnant and having prenatal diagnostic tests; in vitro fertilization (IVF, where embryos are created in a lab and tested before one is transferred to the uterus), with your own or donor eggs or sperm; intrauterine insemination (IUI) with sperm from a donor who is not a carrier; choosing not to get pregnant; or adopting.
If you learn during a pregnancy that you are both carriers, ACOG says your options are more limited. ACMG says counseling should then include offering a diagnostic procedure, as appropriate, to see whether the baby is predicted to have the condition, and talking through decisions about the pregnancy, including preparing for possible medical care after the birth of a child who has the condition.
Two diagnostic tests in pregnancy are chorionic villus sampling (CVS), which takes a small sample of tissue from the placenta, and amniocentesis, which takes a small amount of amniotic fluid, the fluid around the baby, with a thin needle. They can say, with as much certainty as possible, whether the baby has the specific condition tested. ACOG says tests for a specific gene change can be requested, and that a negative result only rules out what was tested. Whether to have a diagnostic test is your choice.
ACMG says that if the pregnant person is a carrier and the partner cannot be tested in time or is unavailable, a diagnostic test can be offered. It adds that a lab may be unable to give a definite diagnosis if one parent’s carrier status is unknown.
Amniocentesis carries a very small chance of pregnancy loss, and the chance with CVS is slightly higher. Certain tests can be done only at certain times in pregnancy, so ask your provider which options are still possible and by when.
ACOG and ACMG say carrier screening does not replace newborn screening.
Questions to ask your provider or a genetic counselor
- Which approach does our practice use for carrier screening, and which conditions does this test cover?
- Will my partner be offered a test at the same time as mine, or only after my result?
- If my result is negative, what chance would remain, and what does the test not look for?
- If we are both carriers, who do we speak to, and how soon can we see a genetic counselor?
- How long do results take, and who will call us?
- Is the test covered by our insurance, and does the same apply to my partner’s test?
- One of us was screened before, or this is a new partnership for one of us: what needs to be repeated or added?
- Does a condition run in either of our families, and should we see a genetic counselor first?
What the partner does
- If the first person tested has a carrier result, the partner is usually offered testing for the same condition. Ask the office whether your test is booked together with your partner’s or after it, and whether you can come to the visit.
- Your family counts too. CDC lists conditions that run in your family or your partner’s family among reasons for genetic counseling. MedlinePlus Genetics says the easiest way to collect a family health history is to talk to relatives about their health. Write down what you learn before the visit and share it with your provider.
- Talk before testing about how each of you would use the results, and what each of you wants to know and when. ACOG says there is no right or wrong choice.
- Agree who will take the call with results and how you want to hear them.
- Check with your insurer, before the sample is taken, what is covered for you and for your partner. ACMG names insurance coverage for patients and partners among the barriers to putting its recommended screening into practice.
- A result can matter to relatives, who may be carriers too. Talk together about whether and how to tell them. Let the person who carries the result make that choice. If you choose to tell family members, ACOG says your ob-gyn or a genetic counselor can advise you on the best way.
- If a result shows you are both carriers, ask for a genetic counselor appointment, go together and take notes. CDC says genetic counseling can be done in person, by phone or by video.
How involved you are is for the two of you to work out. Ask your partner what would help most on the day.
Questions people ask
What is carrier screening?
Carrier screening is a genetic test that shows whether a person carries a gene for certain inherited conditions. Done before or during pregnancy, it shows the chances of having a child with one of them. It tests the parents’ genes, not the baby, and it is a screening test, not a diagnosis. ACOG says it is your choice.
Who should have carrier screening?
ACOG says everyone who is pregnant or planning a pregnancy is offered carrier screening for cystic fibrosis, spinal muscular atrophy and hemoglobinopathies (genetic disorders that affect red blood cells), and calls several approaches acceptable. The American College of Medical Genetics and Genomics (ACMG) says all pregnant patients and those planning a pregnancy should be offered a specific list of conditions it calls Tier 3. Whether to be screened is your choice.
What does a positive carrier screening result mean?
A positive carrier screening result is a carrier result. It means the person has a changed copy of the gene that was tested. ACOG says carriers usually have no symptoms or only mild ones. What it means for a baby depends on the partner, and ACOG says the next step is to have the partner tested. A genetic counselor can explain the results.
Does my partner need to be tested?
If the first person tested is a carrier, the partner is usually offered testing for the same condition. ACOG says the partner who is most likely to be a carrier is typically tested first. The American College of Medical Genetics and Genomics (ACMG) says that in pregnancy it is ideal to test both partners at the same time, so results arrive in time. Ask which your practice does.
Is carrier screening the same as NIPT or cell-free DNA screening?
No. Carrier screening tests the parents’ genes, not the baby, and can be done before or during pregnancy. Cell-free DNA screening, often called NIPT, is a blood test that looks at placental DNA in the pregnant person’s blood to estimate the chance of certain chromosome conditions in the baby, usually from about week 10. It is a screening test, and no sample from the partner is needed.
What conditions does carrier screening test for?
It depends on the test. ACOG says everyone is offered screening for cystic fibrosis, spinal muscular atrophy and hemoglobinopathies (genetic disorders that affect red blood cells), and can choose more. Panels differ between labs and can change over time, so ask which conditions yours covers. Carrier screening is available for a limited number of diseases and does not test for all genetic conditions.
In the app
Sources
- Carrier Screening (FAQ179) (opens in a new tab)ACOG · Updated December 2020; page dated April 2026
- Committee Opinion No. 690: Carrier Screening in the Age of Genomic Medicine (opens in a new tab)ACOG (Obstetrics & Gynecology) · March 2017; ACOG’s page says reaffirmed 2025
- Committee Opinion 690: Carrier Screening in the Age of Genomic Medicine (abstract) (opens in a new tab)ACOG · March 2017; ACOG’s page says reaffirmed 2025
- Committee Opinion 691: Carrier Screening for Genetic Conditions (abstract) (opens in a new tab)ACOG · March 2017; ACOG’s page says reaffirmed 2025
- Carrier Screening for Hemoglobinopathies: Sickle Cell Disease and Thalassemia (FAQ510) (opens in a new tab)ACOG · Updated October 2022; page dated October 2024
- Carrier Screening for Spinal Muscular Atrophy (SMA) (FAQ197) (opens in a new tab)ACOG · Published October 2018; page dated October 2025
- Genetic Disorders and Pregnancy (FAQ094) (opens in a new tab)ACOG · Updated May 2023; page dated April 2025
- Prenatal Genetic Screening Tests (FAQ165) (opens in a new tab)ACOG · Updated October 2020; page dated October 2025
- Prenatal Genetic Diagnostic Tests (FAQ164) (opens in a new tab)ACOG · Updated December 2022; page dated April 2026
- Routine Tests During Pregnancy (FAQ133) (opens in a new tab)ACOG · Updated April 2024; page dated January 2026
- 3 Questions to Ask Yourself Before Getting Prenatal Genetic Testing (opens in a new tab)ACOG · Published October 2020; page dated August 2026
- Screening for Fetal Chromosomal Abnormalities (Practice Advisory) (opens in a new tab)ACOG · January 2026
- Cell-Free DNA Prenatal Screening Test (infographic PFSI008) (opens in a new tab)ACOG · Updated October 2025; page dated October 2025
- Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG) (opens in a new tab)American College of Medical Genetics and Genomics (ACMG) · Published online July 20, 2021; Genetics in Medicine, October 2021 issue (this copy is the text before ACMG’s August 2021 correction)
- Correction to: Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG) (opens in a new tab)American College of Medical Genetics and Genomics (ACMG) · Published August 27, 2021; Genetics in Medicine, October 2021 issue
- SMFM Consult Series #74: Cell-free DNA screening for aneuploidies: updated guidance (opens in a new tab)Society for Maternal-Fetal Medicine (endorsed by ACOG) · November 2025
- Genetic Counseling (opens in a new tab)CDC · January 31, 2025
- Understanding Genetic Carrier Screening: What You Need to Know (opens in a new tab)National Society of Genetic Counselors (patient site) · No date shown on the page; page metadata modified May 8, 2025
- Genetic Discrimination (opens in a new tab)National Human Genome Research Institute (NHGRI, NIH) · Updated January 6, 2022
- What are the different ways a genetic condition can be inherited? (opens in a new tab)MedlinePlus Genetics (NIH) · Updated April 19, 2021
- If a genetic disorder runs in my family, what are the chances that my children will have the condition? (opens in a new tab)MedlinePlus Genetics (NIH) · Updated May 12, 2021
- Why is it important to know my family health history? (opens in a new tab)MedlinePlus Genetics (NIH) · Updated May 12, 2021
- Cystic fibrosis (condition page) (opens in a new tab)MedlinePlus Genetics (NIH) · Updated July 6, 2021
- Prenatal Cell-Free DNA Screening (opens in a new tab)MedlinePlus (NIH) · Updated March 19, 2024
- What is noninvasive prenatal testing (NIPT) and what disorders can it screen for? (opens in a new tab)MedlinePlus Genetics (NIH) · Updated July 28, 2021
Sources last checked:
Medical disclaimer: General info, not medical advice. Your OB, midwife or pediatrician knows your situation; check with them. If something feels wrong, don't wait on an app. Call your provider, or 911 in an emergency. Read the full medical disclaimer